ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO096

Comparison of Urinary Biomarkers in Critically Ill Children: Early Detection of AKI, Prediction of Mortality, and Confounding Factors

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Author

  • Li, Yanhong, children hospital of Soochow University, Suzhou, JiangSu, China
Background

Most AKI biomarkers are susceptible to confounding factors in the prediction. We aimed to compare the performance of urinary biomarkers for early detection of AKI and the prediction of PICU mortality, and investigate the impact of confounding factors on these biomarkers in critically ill children.

Methods

Urine samples were serially collected in 123 children during the first 7 d of PICU stay for measurement of NGAL, KIM-1, TIMP2, IGFBP7, L-FABP, TIMP1, Renin, trefoil factor 3 (TFF-3), interferon-inducible protein-10 (IP-10). AKI diagnosis was based on KDIGO classification.

Results

Of the children, 35 developed AKI, including 12 with stage 1, 14 with stage 2 and 9 with stage 3, and 15 died during PICU stay.
(1). The initial urinary biomarkers, associated with AKI stage 3 in univariate analysis, were TIMP1, KIM-1, NGAL, TIMP2, Renin and L-FABP; and achieved AUC of 0.75, 074, 0.74, 0.71, 0.70, and 0.68 for early detection of AKI stage 3. The initial TIMP1, TIMP2, NGAL, IP-10, KIM-1, L-FABP, TFF-3, Renin and IGFBP-7 achieved AUC of 0.84, 079, 0.78, 0.77, 0.76, 0.74, 0.73, 0.67 and 0.65 for predicting mortality. However, only initial TIMP1 remained associated with AKI stage 3 (P=0.016) and mortality (P=0.038) after adjustment for age, body weight and illness severity.
(2). Peak urinary KIM-1 and TIMP2 remained associated with AKI stage 3; and peak KIM-1, NGAL, L-FABP, and IP-10 remained associated with mortality after adjustment.
(3). Illness severity assessed by PRISM III was identified as an independent factor associated with all the initial and peak urinary biomarkers. Sepsis had an impact on initial and peak levels of NGAL, KIM-1 and IP-10 and peak Renin levels. Furosemide was independently associated with initial and peak levels of NGAL, L-FABP, TIMP1 and Renin and peak KIM-1, TIMP2 and TFF3 levels.

Conclusion

Although a higher initial urinary level of TIMP1, NGAL, KIM-1, TIMP2, Renin or L-FABP is predictive of severe AKI and mortality in critically ill children, these urinary biomarkers are significantly associated with illness severity and influenced by confounding factors. Sepsis has an impact on levels of NGAL, KIM-1, Renin and IP-10. Furosemide affects NGAL, FABP-1, TIMP1 and Renin. Sepsis appeared not to have impact on urinary TIMP1 and TIMP2, in contrast to NGAL and KIM-1, in critically ill children.